Pfizer said today that the European Commission has approved Champix, a novel pill for smoking cessation in adults.
The drugmaker said Champix (varenicline) works by reducing the severity of the smoker's urge to smoke and alleviating many withdrawal symptoms from nicotine. Moreover, if a person...